Assembly Biosciences

Home » Assembly Biosciences

Secondary

Assembly Biosciences

Assembly Biosciences, Inc. is a clinical-stage public biotechnology company developing two innovative platform programs: an HBV program advancing a new class of oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection and a Microbiome program developing novel oral live biotherapeutic candidates, which are designed to treat disorders associated with the microbiome.

Symbol

ASMB

Last Closing Price
$28.58

Shares
1,000,000

Effective Date
November 2, 2017

Underwriters
Jefferies, William Blair

To view the prospectus for Assembly Biosciences, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253